UnitedHealth Group Incorporated (NYSE:UNH) Stock Holdings Trimmed by Corundum Group Inc.

Corundum Group Inc. lessened its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 29.8% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,206 shares of the healthcare conglomerate’s stock after selling 935 shares during the quarter. Corundum Group Inc.’s holdings in UnitedHealth Group were worth $1,290,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of UNH. Northwest Investment Counselors LLC bought a new stake in shares of UnitedHealth Group in the 1st quarter worth approximately $187,000. CHICAGO TRUST Co NA grew its position in shares of UnitedHealth Group by 1.3% during the first quarter. CHICAGO TRUST Co NA now owns 12,509 shares of the healthcare conglomerate’s stock worth $6,188,000 after acquiring an additional 159 shares during the last quarter. Lloyd Advisory Services LLC. lifted its position in UnitedHealth Group by 562.7% in the 1st quarter. Lloyd Advisory Services LLC. now owns 3,910 shares of the healthcare conglomerate’s stock valued at $1,934,000 after purchasing an additional 3,320 shares during the last quarter. Peak Financial Advisors LLC acquired a new stake in shares of UnitedHealth Group in the first quarter valued at approximately $2,850,000. Finally, Traynor Capital Management Inc. boosted its position in shares of UnitedHealth Group by 14.4% during the first quarter. Traynor Capital Management Inc. now owns 1,426 shares of the healthcare conglomerate’s stock worth $705,000 after buying an additional 180 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Stock Up 0.6 %

UNH stock opened at $569.61 on Monday. The business’s 50-day simple moving average is $584.42 and its 200 day simple moving average is $534.68. The company has a quick ratio of 0.88, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The company has a market cap of $525.99 billion, a PE ratio of 37.11, a price-to-earnings-growth ratio of 1.67 and a beta of 0.58. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $608.63.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. The business had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. UnitedHealth Group’s revenue was up 9.2% on a year-over-year basis. During the same period in the prior year, the company posted $6.56 earnings per share. On average, research analysts anticipate that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were given a dividend of $2.10 per share. The ex-dividend date was Monday, September 16th. This represents a $8.40 annualized dividend and a dividend yield of 1.47%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.

Analysts Set New Price Targets

UNH has been the subject of a number of analyst reports. Jefferies Financial Group upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and boosted their price target for the stock from $481.00 to $647.00 in a research report on Wednesday, July 17th. UBS Group reduced their price objective on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. KeyCorp assumed coverage on shares of UnitedHealth Group in a research note on Friday, October 11th. They set an “overweight” rating and a $675.00 price objective for the company. Argus raised their price objective on UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a research report on Wednesday, July 17th. Finally, HSBC downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday. Three investment analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $615.58.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.